ABAnne Breggia

Anne Breggia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anne Breggia has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial Intelligence and Digital Pathology for Histologic Growth Pattern Classification in Lung Adenocarcinoma

    by Muskan Naresh Jain, Salah Mohammed Awad Al-Heejawi, Tejas Mohan Karkera, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T Ryan, Saeed Amal

    Precise histologic pattern classification is essential for lung adenocarcinoma, as it is a primary cause of cancer-related death, to inform successful treatment approaches. The objective of this paper is to compare several deep neural network designs for the categorization of lung cancer histologic patterns. We test various models like DeiT (Data Efficient Image Transformers), CAiT, Swin Transformer, ViT, ResNet, employing Cohen Kappa Score and accuracy measures using hematoxylin and eosin (H&E)-stained formalin-fixed paraffin-embedded (FFPE) whole-slide images of lung adenocarcinoma from the Dartmouth-Hitchcock Medical Center (DHMC) [17]. Our findings highlight the results of each architecture, offering guidance on whether models are suitable for tasks involving the classification of histopathology images.

  • Open Access

    Gastric Cancer Detection with Ensemble Learning on Digital Pathology: Use Case of Gastric Cancer on GasHisSDB Dataset

    by Govind Rajesh Mudavadkar, Mo Deng, Salah Mohammed Awad Al-Heejawi, Isha Hemant Arora, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan, Saeed Amal

    Gastric cancer has become a serious worldwide health concern, emphasizing the crucial importance of early diagnosis measures to improve patient outcomes. While traditional histological image analysis is regarded as the clinical gold standard, it is labour intensive and manual. In recognition of this problem, there has been a rise in interest in the use of computer-aided diagnostic tools to help pathologists with their diagnostic efforts. In particular, deep learning (DL) has emerged as a promising solution in this sector. However, current DL models are still restricted in their ability to extract extensive visual characteristics for correct categorization. To address this limitation, this study proposes the use of ensemble models, which incorporate the capabilities of several deep-learning architectures and use aggregate knowledge of many models to improve classification performance, allowing for more accurate and efficient gastric cancer detection. To determine how well these proposed models performed, this study compared them with other works, all of which were based on the Gastric Histopathology Sub-Size Images Database, a publicly available dataset for gastric cancer. This research demonstrates that the ensemble models achieved a high detection accuracy across all sub-databases, with an average accuracy exceeding 99%. Specifically, ResNet50, VGGNet, and ResNet34 performed better than EfficientNet and VitNet. For the 80 × 80-pixel sub-database, ResNet34 exhibited an accuracy of approximately 93%, VGGNet achieved 94%, and the ensemble model excelled with 99%. In the 120 × 120-pixel sub-database, the ensemble model showed 99% accuracy, VGGNet 97%, and ResNet50 approximately 97%. For the 160 × 160-pixel sub-database, the ensemble model again achieved 99% accuracy, VGGNet 98%, ResNet50 98%, and EfficientNet 92%, highlighting the ensemble model’s superior performance across all resolutions. Overall, the ensemble model consistently provided an accuracy of 99% across the three sub-pixel categories. These findings show that ensemble models may successfully detect critical characteristics from smaller patches and achieve high performance. The findings will help pathologists diagnose gastric cancer using histopathological images, leading to earlier identification and higher patient survival rates.


  • Open Access

    Gastric Cancer Detection with Ensemble Learning on digital pathology: Use Case of Gastric Cancer on GasHisSDB Dataset

    by Govind Rajesh Mudavadkar, Mo Deng, Salah Mohammed Awad Al-Heejawi, Isha Hemant Arora, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan, Saeed Amal

    Gastric cancer has become a serious worldwide health concern, emphasizing the cru-cial importance of early diagnosis measures to improve patient outcomes. While tradi-tional histological image analysis is regarded as the clinical gold standard, it is la-bor-intensive and manual. Recognizing this problem, there has been a rise in interest in using computer-aided diagnostics tools to help pathologists with their diagnostic ef-forts. In particular, deep learning (DL) has emerged as a promising solution in this sector. However, current DL models are still restricted in their ability to extract exten-sive visual characteristics for correct categorization. To tackle this limitation, this study proposes the use of ensemble models, which incorporate the capabilities of sev-eral deep learning architectures and use aggregate knowledge of many models to im-prove classification performance, allowing for more accurate and efficient gastric cancer detection. To see how well these proposed models performed, this study com-pared them to other works, all of which were based on the Gastric Histopathology Sub-size Images Database, a publicly available dataset for gastric cancer. This research demonstrated that the ensemble models achieved high detection accuracy across all sub-databases, with an average accuracy exceeding 99%. Specifically, ResNet50, VGGNet, and ResNet34 performed better than EfficientNet and VitNet. For the 80 × 80 pixel sub-database, ResNet34 exhibited an accuracy of approximately 93%, VGGNet achieved 94%, and the ensemble model excelled with 99%. In the 120 × 120 pixel sub-database, the ensemble model showed 99% accuracy, VGGNet 97%, and ResNet50 approximately 97%. For the 160 × 160 pixel sub-database, the ensemble model again achieved 99% accuracy, VGGNet 98%, ResNet50 98%, and EfficientNet 92%, high-lighting the ensemble model's superior performance across all resolutions. Overall, the ensemble model consistently provided an accuracy of 99% across the three sub-pixel categories. These findings showed that ensemble models may successfully detect criti-cal characteristics from smaller patches and achieve high performance. The findings will help pathologists diagnose gastric cancer using histopathological images, leading to earlier identification and higher patient survival rates.


  • Open Access

    Segmenting Tumor Gleason Pattern using Generative AI and Digital Pathology: Use Case of Prostate Cancer on MICCAI Dataset

    by Saanidhya Vats, Salah Mohammed Awad Al-Heejawi, Tanaya Kondejkar, Anne Breggia, Bilal Ahmad, Robert Christman, Ryan Stephen T, Saeed Amal

    Prostate cancer (PCa) ranks as the second most fatal and sixth most prevalent cancer among males globally. This study focuses on leveraging deep learning networks to detect the Gleason grading of prostate cancer from histopathology images stained with Hematoxylin and Eosin (H&E). Six pathologists annotated the images, resulting in six distinct labels for each input image. A common ground truth label was established through majority voting approach. Subsequently, the dataset was trained using architectures: UNeT, UNeT++, DeepLabV3, DeepLabV3+, and GAN based segmentation network. Notably, GAN based network demonstrated superior performance, achieving an F1-score of 0.872 and a Jaccard Index of 0.777, outperforming the other architectures considered in this study.


  • Open Access

    Multi-Scale Digital Pathology Patch-Level Prostate Cancer Grading Using Deep Learning: Use Case Evaluation of DiagSet Dataset

    by Tanaya Kondejkar, Salah Mohammed Awad Al-Heejawi, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan, Saeed Amal

    Prostate cancer remains a prevalent health concern, emphasizing the critical need for early diagnosis and precise treatment strategies to mitigate mortality rates. The accurate prediction of cancer grade is paramount for timely interventions. This paper introduces an approach to prostate cancer grading, framing it as a classification problem. Leveraging ResNet models on multi-scale patch-level digital pathology and the Diagset dataset, the proposed method demonstrates notable success, achieving an accuracy of 0.999 in identifying clinically significant prostate cancer. The study contributes to the evolving landscape of cancer diagnostics, offering a promising avenue for improved grading accuracy and, consequently, more effective treatment planning. By integrating innovative deep learning techniques with comprehensive datasets, our approach represents a step forward in the pursuit of personalized and targeted cancer care.


  • Top Cited Papers
    Open Access

    Ensemble Deep Learning-Based Image Classification for Breast Cancer Subtype and Invasiveness Diagnosis from Whole Slide Image Histopathology

    by Aadhi Aadhavan Balasubramanian, Salah Mohammed Awad Al-Heejawi, Akarsh Singh, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan, Saeed Amal

    Cancer diagnosis and classification are pivotal for effective patient management and treatment planning. In this study, a comprehensive approach is presented utilizing ensemble deep learning techniques to analyze breast cancer histopathology images. Our datasets were based on two widely employed datasets from different centers for two different tasks: BACH and BreakHis. Within the BACH dataset, a proposed ensemble strategy was employed, incorporating VGG16 and ResNet50 architectures to achieve precise classification of breast cancer histopathology images. Introducing a novel image patching technique to preprocess a high-resolution image facilitated a focused analysis of localized regions of interest. The annotated BACH dataset encompassed 400 WSIs across four distinct classes: Normal, Benign, In Situ Carcinoma, and Invasive Carcinoma. In addition, the proposed ensemble was used on the BreakHis dataset, utilizing VGG16, ResNet34, and ResNet50 models to classify microscopic images into eight distinct categories (four benign and four malignant). For both datasets, a five-fold cross-validation approach was employed for rigorous training and testing. Preliminary experimental results indicated a patch classification accuracy of 95.31% (for the BACH dataset) and WSI image classification accuracy of 98.43% (BreakHis). This research significantly contributes to ongoing endeavors in harnessing artificial intelligence to advance breast cancer diagnosis, potentially fostering improved patient outcomes and alleviating healthcare burdens.


  • Open Access

    Ensemble Deep Learning-Based Image Classification for Breast Cancer Subtype and Invasiveness Diagnosis from Whole Slide Image Histopathology

    by Aadhi Balasubramanian, Salah Mohammed Awad Al-Heejawi, Akarsh Singh, Anne Breggia, Bilal Ahmad, Robert Christman, Ryan Stephen T., Saeed Amal

    Cancer diagnosis and classification are pivotal for effective patient management and treatment planning. In this study, we present a comprehensive approach utilizing ensemble deep learning techniques to analyze breast cancer histopathology images. Our datasets are based on two widely employed datasets from different centers for two different tasks: BACH and BreakHis. Within the BACH Dataset, we deployed an ensemble strategy incorporating VGG16 and ResNet50 architec-tures to achieve precise classification of breast cancer histopathology images. Introducing a novel image patching technique, to preprocess a high-resolution image, which facilitates focused analysis of localized regions of interest. The annotated BACH dataset encompasses 400 WSIs across four distinct classes: Normal, Benign, In Situ Carcinoma, and Invasive Carcinoma. In addition, we employed the BreakHis dataset, utilizing VGG16, ResNet34, and ResNet50 models to classify mi-croscopic images into eight distinct categories (four benign and four malignant). For both models we leveraged a five-fold cross-validation approach for rigorous training and testing. Preliminary ex-perimental results indicate a Patch classification accuracy of 95.31% (on BACH dataset) and WSI image classification accuracy of 98.43% (BreakHis). This research significantly contributes to on-going endeavors in harnessing artificial intelligence to advance breast cancer diagnosis, potentially fostering improved patient outcomes and alleviating healthcare burdens.


  • Open Access

    Multi-Scale Digital Pathology Patch Level Prostate Cancer Grading Using Deep Learning: Use Case Evaluation of DiagSet Dataset

    by Tanaya Kondejkar, Salah Mohammed Awad Al-Heejawi, Anne Breggia, Bilal Ahmad, Robert Christman, Ryan Stephen T, Saeed Amal

    Prostate Cancer remains a prevalent health concern, emphasizing the critical need for early diagnosis and precise treatment strategies to mitigate mortality rates. Accurate prediction of cancer grade is paramount for timely interventions. This paper introduces an approach to prostate cancer grading, framing it as a classification problem. Leveraging ResNet models on multi-scale patch-level digital pathology and the Diagset dataset, the proposed method demonstrates notable success, achieving an accuracy of 0.999 in identifying clinically significant prostate cancer. The study contributes to the evolving landscape of cancer diagnostics, offering a promising avenue for improved grading accuracy and, consequently, more effective treatment planning. By integrating innovative deep-learning techniques with comprehensive datasets, our approach presents a step forward in the pursuit of personalized and targeted cancer care.


  • Open Access

    Enhancing Prostate Cancer Diagnosis with a Novel Artificial Intelligence-Based Web Application: Synergizing Deep Learning Models, Multimodal Data, and Insights from Usability Study with Pathologists

    by Akarsh Singh, Shruti Randive, Anne Breggia, Bilal Ahmad, Robert Christman, Saeed Amal

    Prostate cancer remains a significant cause of male cancer mortality in the United States, with an estimated 288,300 new cases in 2023. Accurate grading of prostate cancer is crucial for ascertaining disease severity and shaping treatment strategies. Modern deep learning techniques show promise in grading biopsies, but there is a gap in integrating these advances into clinical practice. Our web platform tackles this challenge by integrating human expertise with AI-driven grading, incorporating diverse data sources. We gathered feedback from four pathologists and one medical practitioner to assess usability and real-world alignment through a survey and the NASA TLX Usability Test. Notably, 60% of users found it easy to navigate, rating it 5.5 out of 7 for ease of understanding. Users appreciated self-explanatory information in popup tabs. For ease of use, all users favored the detailed summary tab, rating it 6.5 out of 7. While 80% felt patient demographics beyond age were unnecessary, high-resolution biopsy images were deemed vital. Acceptability was high, with all users willing to adopt the app, and some believed it could reduce workload. The NASA TLX Usability Test indicated a low–moderate perceived workload, suggesting room for improved explanations and data visualization.


  • Open Access

    Visualizing Decisions and Analytics of Artificial Intelligence based Cancer Diagnosis and Grading of Specimen Digitized Biopsy: Case Study for Prostate Cancer

    by Akarsh Singh, Michael Wan, Lane Harrison, Anne Breggia, Robert Christman, Raimond L. Winslow, Saeed Amal

    The rise in Artificial Intelligence (AI) and deep learning research has shown great promise in diagnosing prostate cancer from whole slide image biopsies. Intelligent application interface for diagnosis is a progressive way to communicate AI results in the medical domain for practical use. This paper aims to suggest a way to integrate state-of-the-art deep learning algorithms into a web application for visualizations of decisions and analytics of an AI based algorithms applied on cancer digitized specimen biopsies. Performed primarily by visualizing evidence and explanation of the decision using image from the biopsy. By creating smart visualizations of tissue biopsy images, from magnified regions to augmented sharper images along with image masks that highlight cancerous regions of tissue in addition to intelligent analytics and distribution charts related to cancer prediction, we aim to communicate these easily interpretable results to assist pathologists in their workflow for grading prostate cancer biopsies and concerned medical team to make better decisions for prostate cancer diagnosis as case study